<ѻýҕl>Intensive Pretransplant Consolidation in Older AML Fails to Improve Resultsѻýҕl> Newer therapies and strategies might show more promise for boosting survival Sep 07, 2023
<ѻýҕl>Microdevices for Glioma; Cervical Adenocarcinoma Test; Language Gaps and Cancer Careѻýҕl> News, features, and commentary about cancer-related issues Sep 07, 2023
<ѻýҕl>More Intense ALL Therapy Improves Outcomes in Adolescents, Young Adultsѻýҕl> Treatment with "pediatric-inspired protocols" improved event-free, relapse-free survival Sep 07, 2023
<ѻýҕl>Cancer Patients More Likely to Die During COVID Pandemicѻýҕl> Omicron wave was especially deadly, and those with blood cancers at increased risk Sep 01, 2023
<ѻýҕl>Prayer to Cure Cancer; Exercise for Sexual Dysfunction; Carb Intake and Cancerѻýҕl> News, features, and commentary about cancer-related issues Sep 01, 2023
<ѻýҕl>Novel Oral Tx Shows Early Promise in Relapsed/Refractory Myelomaѻýҕl> Mezigdomide led to 41% response rate in heavily pretreated patients Aug 30, 2023
<ѻýҕl>U.S. Unveils First 10 Drugs for Medicare Price Negotiationsѻýҕl> Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
<ѻýҕl>Adenovirus May Trigger Thrombocytopenia, Thrombosis, Case Studies Suggestѻýҕl> First reports of an anti-PF4 disorder associated with an adenovirus infection Aug 09, 2023
<ѻýҕl>Adcetris Plus Chemo Effective in HIV-Related Hodgkin Lymphomaѻýҕl> Researchers call study "practice changing," although outside experts urge caution Aug 04, 2023
<ѻýҕl>Anti-PD-1 Alone Produces Durable Responses in Relapsed/Refractory PMBCLѻýҕl> More than 80% of responding patients remained in response at 4 years Jul 24, 2023
<ѻýҕl>New Recommendations Address Global Inequality in Sickle Cell Disease Careѻýҕl> Commission lays out strategies for progress by 2025 and beyond Jul 13, 2023
<ѻýҕl>Non-Covalent BTK Inhibitor Yields High Response Rate in Pretreated CLLѻýҕl> 73% of patients with prior exposure to covalent BTK inhibitors responded Jul 05, 2023
<ѻýҕl>FDA Gives Nod to Gene Therapy for Hemophilia Aѻýҕl> First gene therapy approved for severe hemophilia A Jun 29, 2023
<ѻýҕl>TXA Holds Its Own for Heavy Menstrual Bleeding in von Willebrand Diseaseѻýҕl> In phase III study, recombinant VWF not superior to cheaper alternative for type 1 and 2 cases Jun 29, 2023
<ѻýҕl>No OS Benefit With Ibrutinib in Early-Stage, High-Risk CLLѻýҕl> Study suggests "watch and wait" should remain standard of care Jun 28, 2023
<ѻýҕl>New Bispecific Antibody Approved for Tough-to-Treat Lymphomaѻýҕl> Approval of glofitamab was based on a phase I/II study that showed a 56% overall response rate Jun 16, 2023
<ѻýҕl>Base-Edited CAR-T Product 'Potent' in Relapsed Childhood T-Cell ALLѻýҕl> One young patient achieved molecular remission within 28 days of infusion Jun 14, 2023
<ѻýҕl>Pre-Existing Depression, Anxiety Tied to Worse DLBCL Prognosisѻýҕl> Patients with depression alone had the worst overall survival Jun 13, 2023
<ѻýҕl>CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Diseaseѻýҕl> Results "indicate that exa-cel can provide a one-time functional cure," says researcher Jun 13, 2023
<ѻýҕl>CAR-T for Chronic Lymphocytic Leukemia Hits Goal of Mid-Stage Trialѻýҕl> All patients had progressed on BTK inhibitors and most had failed venetoclax Jun 12, 2023
<ѻýҕl>Skipping Radiotherapy 'Seems Safe' for PMBCL Patients in Remissionѻýҕl> PET-negative patients after chemoimmunotherapy fared well with observation alone Jun 07, 2023
<ѻýҕl>Second-Line Axi-Cel Bests Standard in Relapsed/Refractory Large B-Cell Lymphomaѻýҕl> The CAR T-cell therapy led to significantly longer overall survival Jun 05, 2023
<ѻýҕl>New Agents for Relapsed/Refractory Myeloma Impress in Early-Stage Clinical Trialsѻýҕl> High rates of deep, durable response with bispecific antibody, rapidly produced CAR T-cell agents Jun 05, 2023
<ѻýҕl>Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDSѻýҕl> Results suggest a "paradigm shift" in the treatment of anemia for these patients May 25, 2023
<ѻýҕl>Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patientsѻýҕl> 5-year OS increased to 100% in standard-risk ALL patients at a Tijuana hospital May 25, 2023
<ѻýҕl>Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AMLѻýҕl> But trial detects "meaningful benefit" when it comes to relapse, editorialists say May 15, 2023
<ѻýҕl>Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomasѻýҕl> Results will likely "encourage a practice change," editorialists say May 10, 2023
<ѻýҕl>FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemiaѻýҕl> Median OS improved from 15 months to nearly 32 months with quizartinib May 09, 2023
<ѻýҕl>Mysterious White Blood Cell Disorder Not Just 'AIDS Without HIV'ѻýҕl> Idiopathic CD4 lymphocytopenia not so heterogenous after all May 03, 2023
<ѻýҕl>Sodium Thiosulphate Not Much Help for Calciphylaxis in CKDѻýҕl> Though used off-label for years, treatment isn't very beneficial Apr 26, 2023
<ѻýҕl>Blinatumomab Plus Chemo Effective in Aggressive Infant ALLѻýҕl> Low incidence of relapse after treatment "remarkable," researchers say Apr 26, 2023
<ѻýҕl>Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCLѻýҕl> Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
<ѻýҕl>Novel Antibody Induces Durable Responses in Heavily Pretreated Myelomaѻýҕl> Overall response rate of 90% in patients who received highest doses of REGN5459 Apr 18, 2023
<ѻýҕl>Oral Drug Improves Sunlight Tolerance in Genetic Photosensitivity Disordersѻýҕl> Dersimelagon significantly extended time to sun-related prodromal symptoms Apr 12, 2023
<ѻýҕl>Blood Donor's Sex Makes No Difference for Survivalѻýҕl> Only difference seen was higher incidence of MRSA infection in recipients of female donor blood Apr 12, 2023
<ѻýҕl>SYK Inhibitor Promising in Early Trial of Primary ITPѻýҕl> Sovleplenib demonstrated "consistent response" as second-line treatment Apr 11, 2023
<ѻýҕl>Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosisѻýҕl> Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
<ѻýҕl>FDA Greenlights First Drug for Rare Immunodeficiency Diseaseѻýҕl> Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
<ѻýҕl>Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosisѻýҕl> A 52-year-old man visited his doctor for a new growth on his nose. Can you diagnosis the patient? Mar 27, 2023
<ѻýҕl>Sam Neill's Rare Lymphomaѻýҕl> The actor noticed swollen glands while on tour for "Jurassic World Dominion" Mar 23, 2023